Caitlin Finney
Dr
B.Sc. (Hons), PhD
caitlin.finney@wimr.org.au
Centre for Immunology and Allergy Research
Neuroinflammation Research Group
Translational Dementia Research Group
Currently open to PHD and Honours students in the topic areas of:
Alzheimer’s disease
Precision medicine
iPSC-derived organoids
Mitochondria
Pharmacology
Predictive modelling Diagnostics

Biography
Dr. Caitlin Finney completed a B.Sc. (Hons) in neuroscience from the University of Toronto and a Ph.D. in Pharmacology & Physiology from the University of New South Wales. Since completing her Ph.D., Dr. Finney has focused on identifying precision medicine-based therapeutic strategies for treating Alzheimer’s disease. In her lab, Dr. Finney uses patient-derived induced pluripotent stem cells to generate in vitro disease models and various techniques including cell imaging and microscopy, high throughput omics, and machine learning. Dr. Finney is also interested in developing new predictive models to improve the diagnosis of Alzheimer’s disease.
Research interests
Alzheimer’s Disease, Dementia, Precision medicine, Genetics, Mitochondria, Pharmacology, Diagnostics, Predictive modelling
Adjunct roles
Adjunct Lecturer | University of Sydney |
Additional information
ORCID: https://orcid.org/0000-0002-9357-8316
Google Scholar: https://scholar.google.com.au/citations?user=k3iEoIcAAAAJ&hl=en
USYD link – https://www.sydney.edu.au/medicine-health/about/our-people/academic-staff/caitlin-finney.html
Current grants
Dementia Australia | 2024-2026 | Precision medicine for late onset Alzheimer’s disease using machine learning and human-derived 3D brain models |
Affiliations
University of Sydney
Awards and recognition
WIMR John & Anne Leece Family Prize, 2023 |